Dialysis: Clinical Trials

3 trials for Dialysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3

Follow Dialysis: new trials by email Literature Review of Dialysis trials Research Report on Dialysis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-finding Study of MCI-196
colestilan-L, colestilan-M, colestilan-H - Chronic Kidney Disease, Dialysis
Phase 3TerminatedTanabe Pharma Corporation102014-04-012015-05-27
Long-term Extension Study of MCI-196
colestilan, CBPB - Chronic Kidney Disease, Dialysis
Phase 3TerminatedTanabe Pharma Corporation62013-08-012015-05-27
A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®), Placebo - Chronic Kidney Disease, Dialysis
Phase 3TerminatedTanabe Pharma Corporation62007-05-012011-11-15

Narrower conditions

Hyperphosphatemia (3)  ·  Renal Insufficiency, Chronic (3)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Phosphorus Metabolism Disorders (3)  ·  Renal Insufficiency (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)

Interventions

cholebine (2)

Sponsors

Tanabe Pharma Corporation (3)

Countries

United Kingdom (3)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  North Macedonia (1)  ·  Poland (1)  ·  Serbia (1)  ·  South Africa (1)  ·  Spain (1)